SARL PHARMACIE DROUOT : revenue, balance sheet and financial ratios

SARL PHARMACIE DROUOT is a French company founded 46 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in CHARMES (88130), this company of category PME shows in 2023 a revenue of 2.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SARL PHARMACIE DROUOT (SIREN 318277258)
Indicator 2024 2023 2022 2020 2019 2017 2016 2015
Revenue N/C 2 620 117 € N/C N/C N/C N/C N/C 2 377 909 €
Net income 7 741 € 31 818 € 126 783 € 57 159 € 65 773 € 91 701 € 69 033 € 63 735 €
EBITDA N/C 66 126 € N/C N/C N/C N/C N/C 151 105 €
Net margin N/C 1.2% N/C N/C N/C N/C N/C 2.7%

Revenue and income statement

In 2024, SARL PHARMACIE DROUOT generates positive net income of 8 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2024: 64 k€ -> 8 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

7 741 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 82%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 34%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

81.689%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

33.948%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

1.5%

Solvency indicators evolution
SARL PHARMACIE DROUOT

Sector positioning

Debt ratio
81.69 2024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average +7 pts over 3 years

In 2024, the debt ratio of SARL PHARMACIE DROUOT (81.69) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
33.95% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average -12 pts over 3 years

In 2024, the financial autonomy of SARL PHARMACIE DROUOT (34.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
2.88 years 2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Good

In 2023, the repayment capacity of SARL PHARMACIE DROUOT (2.88) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 167.51. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

167.508

Liquidity indicators evolution
SARL PHARMACIE DROUOT

Sector positioning

Liquidity ratio
167.51 2024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average -18 pts over 3 years

In 2024, the liquidity ratio of SARL PHARMACIE DROUOT (167.51) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
1.48x 2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average

In 2023, the interest coverage of SARL PHARMACIE DROUOT (1.5x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SARL PHARMACIE DROUOT

Positioning of SARL PHARMACIE DROUOT in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SARL PHARMACIE DROUOT is estimated at 108 070 € (range 75 258€ - 161 679€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
75k€ 108k€ 161k€
108 070 € Range: 75 258€ - 161 679€
NAF 5 année 2024

Valuation method used

Net Income Multiple
7 741 € × 14.0x = 108 070 €
Range: 75 258€ - 161 679€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SARL PHARMACIE DROUOT with other companies in the same sector:

Frequently asked questions about SARL PHARMACIE DROUOT

What is the revenue of SARL PHARMACIE DROUOT ?

The revenue of SARL PHARMACIE DROUOT in 2023 is 2.6 M€.

Is SARL PHARMACIE DROUOT profitable?

Yes, SARL PHARMACIE DROUOT generated a net profit of 8 k€ in 2024.

Where is the headquarters of SARL PHARMACIE DROUOT ?

The headquarters of SARL PHARMACIE DROUOT is located in CHARMES (88130), in the department Vosges.

Where to find the tax return of SARL PHARMACIE DROUOT ?

The tax return of SARL PHARMACIE DROUOT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SARL PHARMACIE DROUOT operate?

SARL PHARMACIE DROUOT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.